cartilage disease: Softening and degeneration of the CARTILAGE. Pathological processes involving the chondral tissue (CARTILAGE).
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
936 |
4. Check minimum number of eventsNone |
936 |
5. Include endpointsNone |
936 |
6. Filter based on genotype QC (FinnGen only) |
936 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M24
- Name in latin
- Alia vitia cartilaginum articularium
Similar endpoints
↥List of similar endpoints to
Other articular cartilage disorders
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7026 | 3215 | 3754 |
| Only index persons | 6071 | 2847 | 3224 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.09 | 0.10 |
| Only index persons | 0.11 | 0.10 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 37.19 | 39.65 | 34.93 |
| Only index persons | 35.55 | 37.92 | 33.46 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 936 | 460 | 476 |
| Unadjusted period prevalence (%) | 0.18 | 0.16 | 0.21 |
| Median age at first event (years) | 35.18 | 34.38 | 35.96 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 869
- Matched controls
- 8689
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M24.1
ICD-10 Finland
Other articular cartilage disorders
+∞
297.4
268
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
37.1
222.3
289
115
72498
ICD-8 Finland
Internal derangement of joint, Alio loco definito
+∞
212.4
195
*
72499
ICD-8 Finland
Internal derangement of joint, Derangement of other joints
+∞
207.8
191
*
7180F
ICD-9 Finland
Other derangement of joint, Articular cartilage disorder[NIVELRUSTON SAIRAUS,POLVI]
+∞
168.3
156
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
153.8
143
*
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
114.8
134.8
144
15
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
22.8
130.6
194
108
1220
FHL
Arthroscopy
46.1
124.7
153
40
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
58.0
109.8
129
26
1223
FHL
Arthroscopy and articular cartilage surgery
1025.0
95.8
92
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
29.0
89.9
123
49
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
52.9
89.6
107
23
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
16.8
88.1
145
102
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
16.8
88.1
145
102
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
314.6
85.2
85
*
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
64.8
80.7
93
16
M01AX05
ATC
glucosamine; oral
6.2
76.5
232
480
M25.5
ICD-10 Finland
Pain in joint
5.1
76.0
287
769
72410
ICD-8 Finland
Internal derangement of joint, Other shoulder derangement
+∞
74.0
70
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
34.8
67.7
88
28
N02AX02
ATC
tramadol; systemic, rectal
3.6
66.9
452
2014
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
133.2
58.6
62
5
M22.4
ICD-10 Finland
Chondromalacia patellae
75.1
55.9
63
9
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
91.9
54.6
60
7
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
53.3
449
2226
M09AX01
ATC
hyaluronic acid; parenteral
18.2
50.9
80
48
M01AH05
ATC
etoricoxib; oral
2.9
49.9
550
3203
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
+∞
48.4
46
*
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
7.5
47.3
118
179
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
45.2
43
*
WX320
NOMESCO Finland
Spinalanesthesy
3.8
43.7
211
668
L15
ICPC
Knee symptom/complaint
4.0
43.6
201
611
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.4
42.9
253
940
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
63.3
41.6
48
8
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
33.7
41.5
54
17
1221
FHL
Arthroscopy and meniscus surgery
25.9
40.2
56
23
M13.9
ICD-10 Finland
Arthritis, unspecified
12.4
39.2
72
63
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
71.4
36.3
41
6
L90
ICPC
Osteoarthrosis of knee
11.6
36.0
68
63
N02BE01
ATC
paracetamol; systemic, rectal
3.2
35.7
754
5853
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
15.8
35.3
58
39
M01AH01
ATC
celecoxib; oral (coxibs)
3.5
35.0
184
615
M20.1
ICD-10 Finland
Hallux valgus (acquired)
12.5
34.6
63
54
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
+∞
34.6
33
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
+∞
34.6
33
*
ZXA05
NOMESCO Finland
Left side
2.9
34.1
245
1021
ZXA00
NOMESCO Finland
Right side
2.9
33.8
261
1135
M79.6
ICD-10 Finland
Pain in limb
2.6
31.5
310
1549
N03AX16
ATC
pregabalin; oral
2.9
30.9
224
928
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
5.9
30.7
90
168
B01AB05
ATC
enoxaparin; parenteral
2.7
30.5
269
1256
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.3
29.8
82
141
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
6.5
29.1
78
129
N03AX12
ATC
gabapentin; oral
3.4
29.0
158
535
1225
FHL
Arthroscopy and other therapeutic procedure
26.1
29.0
40
16
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
155.0
28.8
30
*
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
32.1
28.3
37
12
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
+∞
28.3
27
*
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
5.2
27.9
90
188
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
27.4
321
1726
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.6
27.4
133
411
WX111
NOMESCO Finland
Local infiltration anesthesia
+∞
27.2
26
*
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
5.7
27.2
81
154
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
144.4
26.8
28
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
6.6
26.1
69
112
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.0
26.0
110
302
NFF25
NOMESCO Finland
Cleaning of hip joint, arthroscopic
268.0
25.8
26
*
M03BX02
ATC
tizanidine; oral
2.1
25.3
546
3827
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
+∞
25.1
24
*
S83.2
ICD-10 Finland
Tear of meniscus, current
5.7
24.9
74
140
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
8.4
24.3
54
68
M01AB05
ATC
diclofenac; systemic, rectal
2.1
24.0
577
4190
B01AX06
ATC
[U] rivaroxaban; oral
69.4
23.9
27
*
P01BA02
ATC
hydroxychloroquine; oral
8.0
23.6
54
71
B01AF01
ATC
rivaroxaban; oral
3.9
23.5
104
296
M01AC06
ATC
meloxicam; systemic, rectal
2.2
22.8
309
1747
9254
FHL
Arthrotomy (includes biopsy, revision, loose removal, fixation, and similar procedures)
41.3
22.8
28
7
M17.5
ICD-10 Finland
Other secondary gonarthrosis
235.8
22.7
23
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
9.6
22.5
46
50
M23.8
ICD-10 Finland
Other internal derangements of knee
16.3
22.5
36
23
S18
ICPC
Laceration/cut
2.1
21.8
351
2127
84400
ICD-8 Finland
Sprains and strains of knee and leg
14.5
21.0
35
25
1222
FHL
Arthroscopy and synovial surgery
61.6
21.0
24
*
M25.2
ICD-10 Finland
Flail joint
+∞
20.9
20
*
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
214.8
20.7
21
*
9243
FHL
Plastic of the patella and its tendons
49.2
20.2
24
5
M01AX17
ATC
nimesulide; oral
2.3
20.1
215
1076
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
75.2
19.8
22
*
H02AB06
ATC
prednisolone; systemic
2.0
19.8
376
2408
M02AA07
ATC
piroxicam; topical
2.1
19.4
307
1826
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
16.0
19.4
31
20
X58
ICD-10 Finland
Exposure to other specified factors
2.8
18.9
129
504
71301
ICD-8 Finland
Osteo-arthritis and allied conditions, Arthritis (arthrosis) genus
+∞
18.8
18
*
L13
ICPC
Hip symptom/complaint
3.0
18.7
118
436
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
193.9
18.6
19
*
R03AC02
ATC
salbutamol; inhalant
1.9
18.5
433
2973
ACC51
NOMESCO Finland
Release of median nerve
4.0
18.5
77
208
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
11.4
17.8
33
30
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
68.0
17.8
20
*
M10.9
ICD-10 Finland
Gout, unspecified
5.9
17.8
50
89
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
+∞
17.8
17
*
J01AA02
ATC
doxycycline; systemic
2.0
17.7
670
5430
M24.2
ICD-10 Finland
Disorder of ligament
97.0
17.6
19
*
NBB20
NOMESCO Finland
Primary total prosthetic replacement of humero-scapular joint
97.0
17.6
19
*
M19.2
ICD-10 Finland
Other secondary arthrosis
183.4
17.6
18
*
M20.2
ICD-10 Finland
Hallux rigidus
42.9
17.3
21
5
M01AE02
ATC
naproxen; oral, rectal
1.9
17.3
455
3225
N02AA05
ATC
oxycodone; systemic
2.7
17.2
126
512
R4110
NOMESCO Finland
Physiotherapy
2.1
17.2
227
1241
A02BC02
ATC
pantoprazole; systemic
1.9
17.1
530
3966
M01AE03
ATC
ketoprofen; systemic, rectal
1.9
16.9
321
2021
J01DB01
ATC
cefalexin; oral
2.0
16.8
675
5525
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
4.9
16.7
55
118
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
16.5
158
741
N06AA09
ATC
amitriptyline; systemic
3.1
16.4
97
342
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.0
16.4
67
178
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
40.9
16.4
20
5
L08
ICPC
Shoulder symptom/complaint
2.3
16.2
163
782
J01DA01
ATC
[U] cefalexin; systemic
1.8
16.2
519
3896
M54.5
ICD-10 Finland
Low back pain
2.0
16.2
264
1564
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.3
16.1
84
272
7180A
ICD-9 Finland
Other derangement of joint, Articular cartilage disorder[NIVELRUSTON SAIRAUS,OLKANIVEL]
+∞
15.7
15
*
72490
ICD-8 Finland
NA
+∞
15.7
15
*
NG2AA
NOMESCO Finland
Patella X-ray examination
19.6
15.6
23
12
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
162.7
15.5
16
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
162.7
15.5
16
*
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
38.8
15.4
19
5
NG1DA
NOMESCO Finland
X-ray of knees
38.8
15.4
19
5
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
38.8
15.4
19
5
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
15.4
310
1980
A02BC03
ATC
lansoprazole; oral
2.0
15.2
233
1344
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
6.5
15.2
39
62
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.5
15.1
132
588
L17
ICPC
Foot/toe symptom/complaint
2.1
15.1
196
1058
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.2
15.0
80
264
L04AA13
ATC
leflunomide; oral
32.3
14.8
19
6
1224
FHL
Arthroscopy and loose removal
57.7
14.8
17
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
14.7
236
1381
M19.9
ICD-10 Finland
Arthrosis, unspecified
7.9
14.7
33
43
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.8
14.7
49
107
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
+∞
14.6
14
*
NGF40
NOMESCO Finland
Repair of defect of cartilage in the knee joint with transplant
+∞
14.6
14
*
M07.3
ICD-10 Finland
Other psoriatic arthropathies
+∞
14.6
14
*
M01AE01
ATC
ibuprofen; systemic, rectal
2.1
14.5
748
6478
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
13.7
14.3
24
18
M54.4
ICD-10 Finland
Lumbago with sciatica
2.3
14.2
137
645
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.3
14.0
73
237
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
3.7
14.0
62
177
SPAT1153
SPAT
Removal of sutures
1.9
13.8
248
1507
A02BC01
ATC
omeprazole; systemic
2.0
13.7
220
1283
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.5
13.6
64
192
9271
FHL
Hallux surgery
76.3
13.6
15
*
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
142.0
13.5
14
*
M70.6
ICD-10 Finland
Trochanteric bursitis
2.8
13.4
87
328
72908
ICD-8 Finland
Other diseases of joint, Alii definiti
18.6
13.4
20
11
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.7
13.4
59
168
L40.5
ICD-10 Finland
Arthropathic psoriasis
21.5
13.4
19
9
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.0
13.3
211
1221
NF1AA
NOMESCO Finland
Hip X-ray examination
4.2
13.3
51
128
A02BC05
ATC
esomeprazole; systemic
1.8
13.3
332
2250
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
13.3
278
1780
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.0
13.2
32
47
S83.5
ICD-10 Finland
Sprain and strain involving (anterior)(posterior) cruciate ligament of knee
5.3
13.2
40
79
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
13.1
68
221
R01BA52
ATC
pseudoephedrine, combinations; oral
1.8
12.8
251
1567
J01FA10
ATC
azithromycin; systemic
1.7
12.8
458
3445
M02AA10
ATC
ketoprofen; topical
2.3
12.8
125
588
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
70.9
12.6
14
*
M01AB08
ATC
etodolac; oral
3.0
12.6
74
262
SPAT1202
SPAT
Intra-articular injection
8.9
12.6
26
30
NGC60
NOMESCO Finland
Exchange or addition of patellar part
+∞
12.5
12
*
212
Kela drug reimbursment
Gout
+∞
12.5
12
*
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
12.5
12
*
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
+∞
12.5
12
*
M23.4
ICD-10 Finland
Loose body in knee
+∞
12.5
12
*
NGF20
NOMESCO Finland
Operation for osteochondritis of knee, open
131.7
12.5
13
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
9.2
12.3
25
28
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.4
12.3
60
186
N06AX21
ATC
duloxetine; oral
2.6
12.2
90
366
NGE35
NOMESCO Finland
Plastic repair of ligament of knee not using prosthetic material, anterior cruciate, arthroscopic
7.1
12.2
29
42
M01AE11
ATC
tiaprofenic acid; oral, rectal
4.8
12.1
40
87
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
27.1
12.1
16
6
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
8.8
12.1
25
29
R03DC03
ATC
montelukast; oral
2.2
11.9
133
665
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
4.1
11.8
45
113
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
11.7
91
382
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
16.7
11.7
18
11
M35.7
ICD-10 Finland
Hypermobility syndrome
16.7
11.7
18
11
M48.0
ICD-10 Finland
Spinal stenosis
2.5
11.7
93
395
A07EC01
ATC
sulfasalazine; oral, rectal
4.0
11.6
46
120
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
11.3
11.6
21
19
L89
ICPC
Osteoarthrosis of hip
8.8
11.6
24
28
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
3.8
11.5
49
136
M22.1
ICD-10 Finland
Recurrent subluxation of patella
+∞
11.5
11
*
NGK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of knee or lower leg
+∞
11.5
11
*
7174A
ICD-9 Finland
Internal derangement of knee, Derangement of lateral meniscus
+∞
11.5
11
*
NGC30
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, special prosthesis
+∞
11.5
11
*
D07AC01
ATC
betamethasone; topical
1.7
11.5
271
1787
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
121.5
11.4
12
*
WX110
NOMESCO Finland
Local anesthesy
1.7
11.4
550
4429
NHF25
NOMESCO Finland
Operation for debridement of ankle joint, arthroscopic
15.3
11.3
18
12
A02BA02
ATC
ranitidine; systemic
2.0
11.2
163
911
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
6.2
11.1
29
48
L88
ICPC
Rheumatoid/seropositive arthritis
10.2
11.0
21
21
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
43.9
10.9
13
*
R01AD12
ATC
fluticasone furoate; nasal
1.8
10.9
220
1375
M04AA01
ATC
allopurinol; systemic
2.5
10.9
88
377
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
12.1
10.9
19
16
J04AB02
ATC
rifampicin; systemic
12.1
10.9
19
16
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
10.9
138
730
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
8.4
10.8
23
28
S43.0
ICD-10 Finland
Dislocation of shoulder joint
4.3
10.8
39
94
M22.0
ICD-10 Finland
Recurrent dislocation of patella
60.7
10.6
12
*
TNG10
NOMESCO Finland
Puncture of knee
60.7
10.6
12
*
9255
FHL
Joint auger removal
60.7
10.6
12
*
NGT60
NOMESCO Finland
Forcible manipulation of knee joint
60.7
10.6
12
*
M01AH02
ATC
rofecoxib; oral
2.4
10.6
94
420
72221
ICD-8 Finland
Osteochondrosis, Dissecans
111.2
10.4
11
*
M24.8
ICD-10 Finland
Other specific joint derangements, not elsewhere classified
111.2
10.4
11
*
M25.0
ICD-10 Finland
Haemarthrosis
+∞
10.4
10
*
7180G
ICD-9 Finland
Other derangement of joint, Articular cartilage disorder[NIVELRUSTON SAIRAUS,NILKKA]
+∞
10.4
10
*
NGC20
NOMESCO Finland
Secondary implantation of prosthesis in knee joint, normal prosthesis
+∞
10.4
10
*
NGE10
NOMESCO Finland
Incision or suture of capsule of knee joint
+∞
10.4
10
*
M01CB01
ATC
sodium aurothiomalate; parenteral
+∞
10.4
10
*
73799
ICD-8 Finland
Hallux valgus and varus
+∞
10.4
10
*
E8859
ICD-8 Finland
Fall on same level from slipping, stumbling or tripping
4.0
10.4
41
107
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
12.2
10.4
18
15
L16
ICPC
Ankle symptom/complaint
2.5
10.4
79
328
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
9.7
10.3
20
21
L29
ICPC
Musculoskeletal sympt/complt other
2.9
10.3
63
228
M93.2
ICD-10 Finland
Osteochondritis dissecans
23.7
10.3
14
6
G56.2
ICD-10 Finland
Lesion of ulnar nerve
4.3
10.3
37
89
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
5.7
10.2
28
50
S80.0
ICD-10 Finland
Contusion of knee
3.2
10.1
53
174
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.4
10.1
89
400
WZA00
NOMESCO Finland
Short statement of of health and health related matters
3.5
10.0
46
137
9241
FHL
Due to repeated dislocation of the shoulder joint plastic
40.5
10.0
12
*
WZA90
NOMESCO Finland
Other doctors statement
1.9
10.0
162
940
J01FA06
ATC
roxithromycin; oral
1.6
10.0
321
2291
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
5.3
9.9
29
56
M77.4
ICD-10 Finland
Metatarsalgia
3.7
9.8
42
118
NFB40
NOMESCO Finland
Primary total prosthetic replacement of hip joint using hybrid technique
26.3
9.8
13
5
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
8.9
9.8
20
23
NBF25
NOMESCO Finland
Operation for humeroscapular osteochondritis, arthroscopic
6.6
9.8
24
37
H02AB04
ATC
methylprednisolone; systemic
2.1
9.7
116
598
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
9.7
137
756
M18.0
ICD-10 Finland
Primary arthrosis of first carpometacarpal joints, bilateral
55.6
9.7
11
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
9.6
129
696
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.3
9.6
48
153
RD211
NOMESCO Finland
NA
3.4
9.6
46
142
M01AB55
ATC
diclofenac, combinations; oral
3.1
9.5
51
171
ZX140
NOMESCO Finland
Intra articular
101.0
9.4
10
*
7183A
ICD-9 Finland
Other derangement of joint, Recurrent dislocation of joint[LUXATIO HABITUALIS, OLKANIVEL]
+∞
9.4
9
*
72904
ICD-8 Finland
Other diseases of joint, Dislocatio spontanea
+∞
9.4
9
*
NHG82
NOMESCO Finland
Fusion of other tarsal joint
+∞
9.4
9
*
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
9.4
180
1104
M23.3
ICD-10 Finland
Other meniscus derangements
21.9
9.4
13
6
R06AE07
ATC
cetirizine; oral
1.6
9.3
332
2421
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.5
9.3
75
321
M79.1
ICD-10 Finland
Myalgia
2.2
9.2
95
459
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.2
9.2
46
147
Z50.1
ICD-10 Finland
Other physical therapy
3.2
9.2
46
147
M10.0
ICD-10 Finland
Idiopathic gout
7.8
9.2
20
26
R01AD01
ATC
beclometasone; nasal
1.9
9.1
131
725
R06.0
ICD-10 Finland
Dyspnoea
1.8
9.1
176
1079
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
11.6
9.1
16
14
NF1DA
NOMESCO Finland
X-ray of hips
11.6
9.1
16
14
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
7.1
9.1
21
30
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
3.4
9.0
42
127
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
9.0
541
4468
M19.8
ICD-10 Finland
Other specified arthrosis
5.3
9.0
26
50
R03AC03
ATC
terbutaline; inhalant
2.1
8.8
105
541
TQW40
NOMESCO Finland
Remowal of suture of skin
2.7
8.8
59
228
E883A
ICD-9 Finland
Fall into hole or other opening in surface
3.1
8.7
46
153
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
50.5
8.7
10
*
RF210
NOMESCO Finland
NA
5.3
8.7
25
48
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
8.6
108
566
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
8.6
471
3788
M01AB01
ATC
indometacin; systemic, rectal
2.6
8.6
62
251
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
8.6
79
363
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
20.2
8.5
12
6
T93.3
ICD-10 Finland
Sequelae of dislocation, sprain and strain of lower limb
20.2
8.5
12
6
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
7.4
8.5
19
26
R4120
NOMESCO Finland
Occupational therapy
2.8
8.5
53
196
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.3
8.4
75
337
9056A
ICD-9 Finland
Late effects of musculoskeletal and connective tissue injuries, Late effect of dislocation
90.8
8.4
9
*
NGH20
NOMESCO Finland
Reduction of dislocation of knee joint, open
90.8
8.4
9
*
J01FF01
ATC
clindamycin; systemic
1.7
8.4
197
1280
G47.3
ICD-10 Finland
Sleep apnoea
1.8
8.4
168
1039
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
6.3
8.3
21
34
NGE15
NOMESCO Finland
Incision fo capsule of knee joint, arthroscopic
+∞
8.3
8
*
NGC99
NOMESCO Finland
Other secondary prosthetic replacement inknee joint, other or unspecified
+∞
8.3
8
*
NGC00
NOMESCO Finland
Exchange of a loose part of prosthesis in knee joint
+∞
8.3
8
*
M23.5
ICD-10 Finland
Chronic instability of knee
+∞
8.3
8
*
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
+∞
8.3
8
*
7188E
ICD-9 Finland
Other derangement of joint, Other joint derangement, not elsewhere classified[MB ARTICULI, LIGAM ET CARTILAG AL DEF,LONKKANIVEL]
+∞
8.3
8
*
Z71.8
ICD-10 Finland
Other specified counselling
1.8
8.3
169
1049
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
4.5
8.3
28
64
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
8.2
157
960
J01CA04
ATC
amoxicillin; systemic
1.6
8.1
627
5417
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
8.1
197
1292
9057A
ICD-9 Finland
Late effects of musculoskeletal and connective tissue injuries, Late effect of sprain and strain without mention of tendon injury
17.3
8.1
12
7
M84.1
ICD-10 Finland
Nonunion of fracture [pseudarthrosis]
17.3
8.1
12
7
N04BC05
ATC
pramipexole; oral
2.6
8.1
56
222
L03
ICPC
Low back symptom/complaint
1.8
8.0
162
1003
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
22.2
8.0
11
5
N02AC04
ATC
dextropropoxyphene; oral
4.0
8.0
30
76
NBG10
NOMESCO Finland
Acromioplastia
4.8
8.0
25
53
R05
ICD-10 Finland
Cough
1.8
8.0
139
822
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
3.2
7.9
39
124
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.7
7.9
52
200
L28
ICPC
Limited function/disability (L)
2.0
7.8
98
512
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
7.8
151
922
S83.0
ICD-10 Finland
Dislocation of patella
8.5
7.8
16
19
M15
ICD-10 Finland
Polyarthrosis
4.1
7.8
29
73
L04AB01
ATC
etanercept; parenteral
15.2
7.7
12
8
M96.0
ICD-10 Finland
Pseudarthrosis after fusion or arthrodesis
45.4
7.7
9
*
R01AD09
ATC
mometasone; nasal
1.5
7.7
334
2528
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
7.6
318
2381
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
7.5
285
2087
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
7.5
187
1233
WX002
NOMESCO Finland
Sedation and analgesia
1.8
7.5
138
830
SPAT1212
SPAT
Extensive examination of musculoskeletal system
2.4
7.4
60
257
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.7
7.4
47
177
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
4.2
7.3
26
63
A01
ICPC
Pain general/multiple sites
2.5
7.3
54
221
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
7.3
143
875
M16.3
ICD-10 Finland
Other dysplastic coxarthrosis
+∞
7.3
7
*
NK4EA
NOMESCO Finland
Joint X-ray examintion with load or wrench not elsewhere classified
+∞
7.3
7
*
NG1AD
NOMESCO Finland
Knee CT examination
9.5
7.3
14
15
M01AC01
ATC
piroxicam; systemic, rectal
1.9
7.3
102
560
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
7.3
102
561
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.1
7.2
79
392
M17.2
ICD-10 Finland
Post-traumatic gonarthrosis, bilateral
30.3
7.2
9
*
L20
ICPC
Joint symptom/complaint NOS
4.1
7.1
26
65
ZXA10
NOMESCO Finland
Bilateral
1.8
7.1
132
798
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.1
7.1
18
30
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
6.1
7.1
18
30
E0000UV
ATC
NA
1.5
7.1
273
2003
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
7.1
374
2936
WX200
NOMESCO Finland
Interscalenous plexus blockade
4.8
7.0
22
47
M16
ICD-10 Finland
Coxarthrosis [arthrosis of hip]
4.8
7.0
22
47
R52.1
ICD-10 Finland
Chronic intractable pain
10.1
7.0
13
13
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.5
7.0
391
3100
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.5
6.9
30
87
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
6.9
66
309
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
5.5
6.9
19
35
WX204
NOMESCO Finland
Axillary plexus blockaced
4.1
6.9
25
62
NB1AD
NOMESCO Finland
Shoulder CT examination
7.6
6.9
15
20
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
6.9
146
918
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
13.9
6.9
11
8
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
13.9
6.9
11
8
8449X
ICD-9 Finland
Sprains and strains of knee and leg, Unspecified site of knee and leg
13.9
6.9
11
8
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
13.9
6.9
11
8
XA402
NOMESCO Finland
ENMG
4.2
6.8
24
58
NGB10
NOMESCO Finland
Primary partial prosthetic replacement of knee joint, demi prosthesis
40.3
6.8
8
*
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
40.3
6.8
8
*
9244
FHL
Plastic or reconstruction of ligaments of the knee other than the lumbar region
16.8
6.7
10
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
6.7
203
1400
M03BC51
ATC
orphenadrine, combinations; systemic
1.6
6.7
210
1464
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
6.6
116
684
S83.3
ICD-10 Finland
Tear of articular cartilage of knee, current
7.9
6.6
14
18
WX702
NOMESCO Finland
Supraglottic ventilation device
2.9
6.6
38
134
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.6
6.6
44
172
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.9
6.6
25
65
M01AH03
ATC
valdecoxib; oral
2.4
6.6
53
229
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.3
6.6
58
262
RF410
NOMESCO Finland
NA
8.8
6.6
13
15
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.7
6.5
42
159
92700
ICD-8 Finland
Contusion of hip, thigh, leg and ankle, Current injury
10.1
6.5
12
12
H02AB07
ATC
prednisone; oral
1.9
6.5
96
537
AA1AD
NOMESCO Finland
CT of head and brain
1.6
6.5
176
1182
M54.3
ICD-10 Finland
Sciatica
2.5
6.5
47
193
L01
ICPC
Neck symptom/complaint
1.9
6.5
90
492
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
5.4
6.5
18
34
NFB50
NOMESCO Finland
Primary total prosthetic replacement of hip joint using cement
70.3
6.4
7
*
NGF30
NOMESCO Finland
Fixation of loose body of joint of knee
70.3
6.4
7
*
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
14.4
6.4
10
7
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
14.4
6.4
10
7
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
6.4
244
1777
J01FA09
ATC
clarithromycin; systemic
1.5
6.4
231
1661
NH1AD
NOMESCO Finland
Ankle and foot CT
5.0
6.4
19
39
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
5.0
6.4
19
39
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.5
6.3
46
189
L04AB04
ATC
adalimumab; parenteral
8.2
6.3
13
16
R03BA05
ATC
fluticasone; inhalant
1.7
6.3
130
810
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.6
6.3
26
73
SPAT1229
SPAT
Assessment of need for aid
2.4
6.3
51
221
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
6.3
204
1432
M54.6
ICD-10 Finland
Pain in thoracic spine
2.5
6.3
48
202
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
6.3
54
242
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.3
288
2183
NH1EA
NOMESCO Finland
Ankle X-ray examination with load or wrench
+∞
6.3
6
*
NHG22
NOMESCO Finland
Fusion of subtalar joint
+∞
6.3
6
*
7183F
ICD-9 Finland
Other derangement of joint, Recurrent dislocation of joint[LUXATIO HABITUALIS, POLVI]
+∞
6.3
6
*
NG2CA
NOMESCO Finland
X-ray of patella with specialised projection
+∞
6.3
6
*
7176A
ICD-9 Finland
Internal derangement of knee, Loose body in knee
+∞
6.3
6
*
NBC40
NOMESCO Finland
Secondary implantation of prosthesis in humeroscapular joint, both parts
+∞
6.3
6
*
NDG30
NOMESCO Finland
Fusion of wrist, total
+∞
6.3
6
*
7152F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, secondary[OSTEORTHROSIS SECUNDARIA,POLVI]
+∞
6.3
6
*
7180E
ICD-9 Finland
Other derangement of joint, Articular cartilage disorder[NIVELRUSTON SAIRAUS,LONKKANIVEL]
+∞
6.3
6
*
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
4.8
6.2
19
40
M94.2
ICD-10 Finland
Chondromalacia
26.9
6.2
8
*
NBB10
NOMESCO Finland
Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified
26.9
6.2
8
*
D07AC13
ATC
mometasone; topical
1.5
6.1
209
1483
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
2.0
6.1
79
422
R09
ICPC
Sinus symptom/complaint
2.4
6.0
49
212
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
6.1
6.0
15
25
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.1
6.0
31
104
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
54
48
11.88
52.18
1.4
1.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
42
42
10.42
37.38
1.6
1.1
e6/l
10173.6
12938.1
0.17
31
29
(3021788) Differential panel - Synovial fluid
29
21
14.22
31.47
1.7
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
199
863
2.66
29.84
1.3
1.2
iu/ml
24.5
17.6
0.77
60
246
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
16
16.03
28.92
1.6
1.1
%
55.6
74.5
—
14
10
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
187
798
2.68
28.88
1.3
1.1
u/ml
4.0
1.5
0.65
81
333
(3044941) Cell count panel - Synovial fluid
31
31
10.31
27.50
1.4
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
645
5060
1.88
17.40
4.8
3.1
mm/h
11.4
11.6
0.19
612
4634
(3026493) Urate [Moles/volume] in Serum or Plasma
271
1663
1.89
16.02
2.9
2.4
umol/l
2133.8
8473.5
2.26
237
1454
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
436
3097
1.76
15.82
4.3
3.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
169
885
2.11
15.69
2.3
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
683
5565
1.84
15.03
7.7
7.4
u/l
77.2
78.4
0.41
659
5242
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
333
2228
1.77
14.57
2.8
2.6
u/l
54.4
58.7
0.77
312
2061
(3006315) Basophils [#/volume] in Blood
461
3393
1.71
14.21
5.6
5.0
e9/l
0.0
0.0
0.97
409
2885
(3001604) Monocytes [#/volume] in Blood
459
3384
1.70
13.99
5.6
5.0
e9/l
0.6
0.6
0.13
404
2871
(3037522) Nuclear Ab [Titer] in Serum
136
684
2.16
13.93
1.2
1.3
titre
426.7
484.1
0.20
33
127
(3013115) Eosinophils [#/volume] in Blood
473
3523
1.69
13.81
5.7
5.3
e9/l
0.2
0.2
0.79
422
3039
(3019198) Lymphocytes [#/volume] in Blood
467
3480
1.68
13.50
5.7
5.0
e9/l
1.9
1.9
0.11
417
3012
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
243
1516
1.81
13.27
1.7
1.7
mg/l
0.9
1.3
2.38
196
1156
(3013826) Glucose [Moles/volume] in Serum or Plasma
536
4266
1.60
10.98
4.5
5.0
mmol/l
6.7
6.8
0.15
514
3996
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
489
3814
1.59
10.87
5.2
6.8
umol/l
11.0
12.0
0.65
467
3620
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
822
7348
1.97
10.60
16.8
12.7
mg/l
22.8
26.7
2.36
696
5599
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
107
545
2.09
10.53
3.6
2.6
ml/min/173m2
66.7
66.4
0.02
40
209
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
297
2089
1.62
10.00
2.2
2.1
u/l
271.4
283.0
0.05
285
1965
(3037467) Urinalysis macro (dipstick) panel - Urine
580
4760
1.57
9.96
4.8
3.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
346
2526
1.59
9.96
3.7
2.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
331
2425
1.56
9.22
3.9
3.4
e6/l
52.4
140.6
1.72
260
1733
(3015171) Extractable nuclear Ab [Units/volume] in Serum
51
199
2.65
9.21
1.1
1.2
u/ml
0.4
1.0
—
9
13
(3008898) HLA-B27 [Presence]
41
144
2.93
9.01
1.1
1.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
412
3182
1.53
8.97
5.8
5.1
%
2.9
2.9
0.07
382
2963
(3035350) Ketones [Presence] in Urine by Test strip
432
3372
1.52
8.94
4.1
3.2
estimate
0.0
0.0
0.00
83
593
(3031040) Bacteria [#/volume] in Urine by Automated count
552
4544
1.52
8.84
4.9
3.9
e6/l
2.6
1750.1
—
5
70
(3009261) Glucose [Presence] in Urine by Test strip
435
3414
1.51
8.69
4.2
3.2
estimate
0.0
0.0
0.80
82
569
(3023368) Bacteria identified in Blood by Culture
271
1920
1.58
8.63
4.4
4.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
404
3128
1.51
8.57
5.6
6.3
mmol/l
1.2
1.2
0.37
376
2820
(3030467) Casts [#/volume] in Urine by Automated count
270
1915
1.58
8.55
3.4
2.9
e6/l
0.2
0.6
4.64
225
1424
(3018418) pH of Serum or Plasma
281
2013
1.57
8.51
3.8
4.0
ph
7.4
7.4
0.01
58
390
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
437
3443
1.51
8.51
6.8
7.1
mmol/l
1.2
1.2
0.36
387
2912
(3022096) Basophils/100 leukocytes in Blood
399
3091
1.51
8.39
5.6
5.1
%
0.7
0.7
0.28
372
2884
(42870588) Differential panel, method unspecified - Blood
307
2250
1.54
8.37
5.4
5.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
374
2862
1.51
8.33
8.7
8.7
inr
1.2
1.2
0.40
117
841
(3024561) Albumin [Mass/volume] in Serum or Plasma
394
3053
1.50
8.23
5.1
5.2
g/l
35.7
35.6
0.18
373
2845
(3013650) Neutrophils [#/volume] in Blood by Automated count
501
4081
1.49
8.16
8.2
9.0
e9/l
4.0
4.1
0.24
449
3532
(3021601) Nitrite [Presence] in Urine by Test strip
428
3378
1.49
8.15
5.3
4.4
estimate
0.0
0.0
0.50
80
606
(3018010) Neutrophils/100 leukocytes in Blood
412
3234
1.49
8.02
5.7
5.0
%
57.0
57.2
0.12
384
3035
(36304419) Bacteria [Presence] in Urine
262
1873
1.55
7.92
3.3
2.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
407
3196
1.48
7.86
6.4
5.4
%
8.6
8.7
0.41
382
2994
(3002030) Lymphocytes/100 leukocytes in Blood
416
3285
1.48
7.79
5.9
5.2
%
28.0
27.8
0.21
386
3063
(3044889) 12 lead EKG panel
623
5344
1.50
7.57
3.7
3.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
78
402
2.03
7.44
1.4
1.2
u/ml
506.4
259.1
0.63
73
366
(3002582) Erythrocytes [#/volume] in Urine
287
2120
1.51
7.38
3.6
3.0
e6/l
25.2
66.8
3.78
236
1616
(3029937) Albumin [Presence] in Urine by Test strip
251
1810
1.53
7.20
4.7
3.3
estimate
0.0
0.0
1.08
82
581
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
357
2767
1.47
7.19
2.4
2.1
nmol/l
74.9
76.4
0.48
334
2482
(3024263) Appearance of Synovial fluid
10
13
7.76
7.13
1.4
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
170
1151
1.58
6.39
2.9
2.6
e6/l
1.2
1.0
0.27
112
652
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
26
86
3.08
6.38
2.0
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
347
2728
1.43
6.28
3.9
3.4
ng/l
40.8
58.4
0.55
253
1878
(3044640) Blood type and Crossmatch panel - Blood
281
2124
1.46
6.27
2.6
2.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
204
1446
1.53
6.24
2.9
2.4
e6/l
5.9
5.9
0.01
183
1256
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
227
1649
1.50
6.17
2.3
1.9
mg/l
3.1
2.9
0.65
202
1363
(3021589) Normoblasts [#/volume] in Blood
395
3189
1.41
6.11
9.1
8.5
e9/l
0.0
0.0
0.41
341
2572
(3019550) Sodium [Moles/volume] in Serum or Plasma
840
7819
1.72
6.03
18.1
15.1
mmol/l
139.5
139.7
1.30
831
7591
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
134
871
1.63
5.95
2.4
2.5
%
22.5
24.0
0.54
124
748
(3012516) Albumin [Mass/volume] in Urine
284
2170
1.44
5.93
3.1
3.1
mg/l
433.4
440.1
0.01
205
1358
(40760892) CBC W Ordered Manual Differential panel - Blood
209
1505
1.50
5.90
4.4
4.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
360
2874
1.41
5.88
3.2
2.5
ug/l
126.8
151.8
1.25
344
2658
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
38
161
2.42
5.87
1.3
1.9
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
842
7853
1.72
5.86
18.4
15.2
mmol/l
4.0
4.0
1.02
832
7613
(3011397) Hemoglobin [Presence] in Urine by Test strip
208
1502
1.49
5.79
3.9
3.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
628
5522
1.42
5.76
4.3
3.8
pmol/l
14.8
14.8
0.09
583
5012
(3007853) Bacteria identified in Skin by Aerobe culture
117
745
1.65
5.63
1.8
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
124
807
1.62
5.47
1.7
1.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
841
7866
1.68
5.47
15.7
12.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
352
2826
1.39
5.47
1.9
1.9
pmol/l
93.7
93.2
0.07
191
1500
(3009508) Creatinine [Moles/volume] in Urine
291
2265
1.41
5.40
3.5
3.0
mmol/l
7.7
7.8
0.09
258
1918
(3033658) Prothrombin time (PT) actual/Normal
243
1837
1.44
5.29
3.9
3.9
%
93.8
89.8
1.70
235
1795
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
297
2333
1.40
5.19
2.6
3.3
u/l
30.4
33.3
1.24
268
2223
(3022217) INR in Platelet poor plasma by Coagulation assay
130
871
1.57
5.08
20.5
22.0
inr
1.3
1.4
0.22
16
113
(3021960) Folate [Moles/volume] in Serum or Plasma
215
1602
1.44
5.04
1.5
1.5
nmol/l
20.9
20.4
0.17
191
1374
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
160
1129
1.50
4.93
1.7
1.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
79
469
1.75
4.93
3.8
4.2
%
0.0
0.1
1.21
17
125
(3020682) Albumin/Creatinine [Ratio] in Urine
291
2295
1.39
4.93
4.0
3.8
mg/mmol
20.4
8.3
0.50
204
1451
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
737
6747
1.43
4.81
5.1
4.4
mu/l
1.9
2.4
0.91
696
6142
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
121
809
1.57
4.77
1.7
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
213
1607
1.42
4.63
2.6
2.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
72
425
1.75
4.59
2.7
3.1
e9/l
4.3
4.0
0.47
55
333
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
326
2652
1.35
4.46
4.5
3.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
761
7039
1.43
4.41
6.3
5.4
mmol/mol
40.5
39.9
0.96
721
6494
(3003327) Ova and parasites identified in Stool by Light microscopy
39
190
2.10
4.40
1.6
1.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
251
1964
1.38
4.38
3.7
2.9
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
35
164
2.18
4.36
1.5
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
686
6244
1.37
4.30
18.9
15.9
%
13.8
13.7
1.04
674
6099
(3019150) Specific gravity of Urine by Refractometry
196
1475
1.42
4.30
4.9
3.3
kg/l
1.0
1.0
0.44
26
197
(4034850)
49
262
1.92
4.29
8.9
9.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
68
405
1.73
4.22
2.8
3.5
mmol/l
1.8
1.8
0.02
47
315
(3021440) Promyelocytes/100 leukocytes in Blood
80
499
1.66
4.19
3.8
4.3
%
0.1
0.1
0.19
19
152
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
115
2.39
4.19
2.1
2.3
u/l
313.1
2647.9
—
7
44
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
167
2.14
4.18
1.7
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
171
1262
1.43
4.17
1.3
1.5
g/l
2.2
2.5
1.63
109
769
(3017181) Myelocytes/100 leukocytes in Blood
83
533
1.61
3.89
3.7
4.2
%
1.3
0.9
0.38
19
165
(3045414) Leukocytes [Presence] in Urine
51
286
1.83
3.89
2.6
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
86
558
1.60
3.87
3.6
3.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
116
806
1.50
3.85
1.4
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
77
489
1.63
3.78
3.6
4.1
%
0.6
0.7
0.12
14
115
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
31
147
2.15
3.78
1.7
1.6
iu/ml
0.0
0.3
—
5
29
(40758558) Short blood count panel - Blood
223
1751
1.36
3.75
7.3
6.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
34
170
2.04
3.63
1.3
1.1
—
—
—
0
0
(3009343) pH of Capillary blood
68
424
1.65
3.60
2.9
3.5
ph
7.4
7.4
0.15
13
50
(3016502) Oxygen saturation in Arterial blood
108
751
1.50
3.57
5.9
9.5
%
95.2
95.7
0.24
102
729
(3008152) Bicarbonate [Moles/volume] in Arterial blood
73
465
1.62
3.55
4.5
8.0
mmol/l
24.6
24.4
0.18
67
436
(3003458) Phosphate [Moles/volume] in Serum or Plasma
130
940
1.44
3.53
6.2
5.9
mmol/l
1.1
1.0
0.51
124
868
(4010399)
79
517
1.58
3.45
1.4
1.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
59
359
1.69
3.43
1.3
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
179
1376
1.37
3.42
3.2
2.6
mosm/kgh2o
554.8
552.9
0.03
156
1157
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
110
775
1.48
3.42
1.5
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
325
1.70
3.28
2.6
2.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
147
1104
1.39
3.23
3.3
2.7
e6/l
1.8
1.9
0.16
91
601
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
65
413
1.62
3.22
1.4
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
768
7220
1.35
3.17
14.4
11.9
ml/min/173m2
81.0
81.2
0.10
679
5916
(3017446) Testosterone [Moles/volume] in Serum or Plasma
86
590
1.50
3.06
2.5
2.3
nmol/l
13.0
12.8
0.11
76
523
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
27
133
2.06
3.04
1.1
1.2
u/ml
2.1
3.3
—
6
24
(3044290) Cell count panel - Cerebral spinal fluid
27
134
2.05
2.98
1.0
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
184
1451
1.33
2.97
1.3
1.2
u/ml
1.7
1.9
0.09
46
386
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
29
149
1.98
2.92
1.2
1.5
e6/l
2.2
4.1
1.00
22
114
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
29
149
1.98
2.92
1.2
1.6
e6/l
243.2
681.3
0.39
22
118
(3006184) Hemoglobin [Mass/volume] in Capillary blood
27
137
2.00
2.82
1.8
2.4
g/l
129.0
128.5
0.03
21
102
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
23
3.94
2.78
1.0
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
106
774
1.42
2.75
1.9
2.3
ug/g
276.7
154.7
0.73
77
620
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
24
3.78
2.67
1.1
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
113
839
1.39
2.67
5.8
9.1
kpa
5.1
5.1
0.00
107
805
(3027801) Oxygen [Partial pressure] in Arterial blood
113
839
1.39
2.67
5.7
9.1
kpa
12.1
12.3
0.13
107
807
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
847
8136
1.43
2.67
11.6
9.2
u/l
26.9
26.9
0.02
834
7841
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
547
4974
1.24
2.66
3.4
3.0
u/l
51.4
52.7
0.12
520
4661
(3025130) Human papilloma virus identified in Specimen
16
67
2.41
2.64
1.6
2.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
73
505
1.48
2.53
3.7
3.8
ng/l
115.4
92.0
0.43
65
436
(36660697) Celiac disease serology panel - Serum
73
507
1.48
2.48
1.1
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
90
652
1.42
2.46
1.5
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
20
96
2.11
2.44
1.2
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
189
1.77
2.44
1.5
1.4
ug/g
168.3
275.6
1.67
14
116
(3017569) Oxygen content in Arterial blood
10
34
2.96
2.41
1.8
3.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
21
104
2.04
2.37
1.0
1.3
u/ml
39.2
49.1
—
5
12
(3022313) Gas panel - Capillary blood
48
309
1.58
2.32
2.8
3.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
109
825
1.36
2.31
2.3
2.9
umol/l
9.0
9.3
0.03
96
717
(3011985) Renin [Units/volume] in Plasma
20
99
2.04
2.27
1.1
1.4
mu/l
220.1
60.0
0.83
20
89
(3007461) Platelets [#/volume] in Blood
875
8491
1.47
2.23
24.1
18.5
e9/l
251.5
248.8
0.60
865
8226
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
812
7788
1.32
2.22
5.2
4.7
mmol/l
2.7
2.8
3.26
764
7180
(3019060) Gas panel - Arterial blood
69
486
1.45
2.21
3.3
5.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
166
1.77
2.17
1.3
1.4
u/l
8.3
9.7
0.27
21
131
(3042631) Mycobacterium sp identified in Specimen
19
94
2.04
2.17
2.4
2.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
875
8497
1.46
2.16
24.1
18.5
e12/l
4.5
4.5
0.10
862
8215
(4062490)
14
61
2.31
2.15
1.5
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
61
2.31
2.15
1.4
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
875
8499
1.45
2.13
24.1
18.5
e9/l
6.8
6.6
1.57
864
8218
(3000963) Hemoglobin [Mass/volume] in Blood
875
8500
1.45
2.12
24.1
18.6
g/l
136.0
136.9
0.96
870
8350
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
68
2.23
2.12
1.0
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
798
7647
1.30
2.10
4.5
4.3
mmol/l
4.6
4.7
1.57
752
7083
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
61
424
1.47
2.10
1.6
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
56
0.00
2.06
0.0
18.9
—
1549.8
—
0
56
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
172
1412
1.27
2.05
3.6
3.6
ng/l
147.7
534.5
3.13
131
1088
(3006576) Bicarbonate [Moles/volume] in Blood
8
26
3.09
2.01
3.9
10.7
mmol/l
29.9
25.9
—
8
26
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
26
3.09
2.01
2.9
3.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
14
63
2.24
2.01
1.9
1.2
nmol/l
2.3
1.5
0.87
14
58
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
38
2.65
2.01
1.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
38
2.65
2.01
1.2
1.1
—
—
—
0
0
(3036489) Thrombin time
41
266
1.57
1.95
1.7
1.9
s
23.5
22.0
0.31
34
238
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
228
1944
1.23
1.94
2.9
3.0
ng/l
1017.3
1255.5
0.51
193
1651
(3022621) pH of Urine by Test strip
59
415
1.45
1.93
5.7
2.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
71
2.13
1.93
1.6
2.0
—
19.8
—
0
23
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
99
1.94
1.91
2.2
2.1
g/l
1.0
1.0
0.02
14
76
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
92
1.98
1.91
1.1
1.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
279
2434
1.21
1.88
3.3
3.9
mmol/l
2.4
2.4
0.11
257
2163
(3004588) Protein electrophoresis panel - Serum or Plasma
59
418
1.44
1.87
2.0
2.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
23
129
1.80
1.87
3.7
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
93
712
1.34
1.87
3.2
3.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
40
2.52
1.84
1.2
1.1
nmol/l
151.4
143.5
—
10
40
(3049717) Cytology report of Urine Cyto stain
44
295
1.52
1.83
2.6
2.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
108
1.87
1.82
2.2
3.6
%
57.9
56.7
0.16
20
108
(3020891) Body temperature
43
287
1.52
1.82
3.1
4.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
22
123
1.81
1.81
1.5
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
35
2.59
1.80
1.3
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
77
576
1.37
1.80
3.0
3.7
mmol/l
1.2
1.2
0.12
68
489
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
30
185
1.64
1.77
2.3
2.4
ug/min
86.0
163.0
0.55
20
110
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
68
500
1.39
1.76
1.4
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
789
7587
1.25
1.76
4.4
4.2
mmol/l
1.4
1.5
0.53
741
6985
(3021879) Hepatitis B virus core Ab [Presence] in Serum
56
398
1.43
1.76
1.4
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
30
2.68
1.72
1.5
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
103
1.86
1.72
2.3
3.0
e9/l
4.4
4.2
0.19
19
103
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
13
3.86
1.71
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
13
3.86
1.71
1.0
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
88
680
1.32
1.68
2.5
2.5
u/l
30.4
41.4
1.95
70
583
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
122
986
1.27
1.67
1.5
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
19
3.17
1.66
2.3
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
106
845
1.29
1.62
6.1
9.0
mmol/l
1.3
1.1
0.20
83
664
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
32
2.51
1.60
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
77
1.96
1.60
9.0
1.7
—
—
—
0
0
(4024509)
11
50
2.21
1.57
1.2
1.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
17
92
1.86
1.56
1.1
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
40
273
1.49
1.56
1.1
1.3
—
7.8
—
0
6
(3026389) Candida sp identified in Specimen by Organism specific culture
15
78
1.94
1.55
1.1
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
185
1.59
1.53
1.1
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
15
3.35
1.52
1.0
1.0
—
—
—
0
0
(3013512) EKG study
234
2047
1.19
1.51
4.1
3.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
178
1.59
1.50
5.3
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
772
7438
1.22
1.49
4.8
4.3
mmol/l
6.0
6.0
0.70
727
6797
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
61
455
1.36
1.49
1.8
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
28
179
1.58
1.47
5.3
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
187
1.57
1.47
1.1
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
16
87
1.85
1.46
1.1
1.4
nmol/l
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
180
1.57
1.44
5.3
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
216
1885
1.19
1.43
4.1
2.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
141
1.65
1.42
1.2
1.4
—
—
—
0
0
(44813793)
9
40
2.26
1.40
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
98
791
1.27
1.38
1.2
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
479
4459
1.15
1.37
2.7
2.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
104
1.75
1.37
1.2
1.2
u/ml
4.6
7.3
—
5
31
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
156
1326
1.21
1.37
3.0
3.3
mmol/l
2.5
2.5
0.02
145
1188
(3004716) Salmonella sp identified in Stool by Organism specific culture
44
317
1.41
1.33
1.3
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
28
184
1.54
1.33
1.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
27
176
1.55
1.33
5.5
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
63
482
1.33
1.33
1.2
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
267
2971
0.86
1.32
2.8
2.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
19
113
1.70
1.32
1.4
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
15
83
1.82
1.32
1.1
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
51
380
1.36
1.28
3.2
2.6
e6/l
0.3
0.2
0.22
51
369
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
48
2.10
1.28
1.6
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
75
592
1.29
1.27
2.4
2.7
ng/l
100.0
190.8
3.11
70
538
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
146
1.59
1.27
1.3
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
115
956
1.23
1.27
1.3
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
29
195
1.50
1.25
4.3
3.5
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
6
25
2.41
1.24
1.2
1.1
%
90.2
89.7
—
6
19
(3003888) Timothy IgE Ab [Units/volume] in Serum
15
85
1.78
1.23
1.1
1.0
u/ml
1.7
8.2
—
7
38
(3037556) Urate [Mass/volume] in Serum or Plasma
5
19
2.64
1.21
1.0
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
37
2.17
1.21
2.5
1.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
19
117
1.64
1.18
3.9
2.8
—
—
—
0
0
(4027681)
8
38
2.11
1.18
1.4
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
318
2902
1.15
1.17
4.5
4.6
ug/l
2.0
3.0
1.54
297
2610
(3019309) Folate [Moles/volume] in Red Blood Cells
143
1225
1.20
1.17
1.6
1.6
nmol/l
1314.5
1174.6
0.67
109
935
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
59
754
0.77
1.17
1.9
1.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
142
1218
1.20
1.15
3.1
3.6
mmol/l
0.8
0.8
0.87
134
1154
(3015183) Erythrocyte sedimentation rate
8
39
2.06
1.15
1.0
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
72
1.82
1.15
1.0
1.7
—
—
—
0
0
(4198724)
5
20
2.51
1.15
1.0
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
65
1.86
1.13
1.1
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
756
7319
1.17
1.13
4.0
3.8
mmol/l
1.4
1.3
1.80
702
6706
(3014271) Vancomycin [Susceptibility]
7
30
2.34
1.12
1.7
2.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
58
1.91
1.12
1.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
22
143
1.55
1.12
1.9
2.5
%
16.7
16.4
0.13
14
72
(3043409) Potassium [Moles/volume] in Arterial blood
32
226
1.43
1.11
3.0
3.3
mmol/l
3.9
3.9
0.25
32
211
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
106
888
1.22
1.10
7.5
6.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
27
185
1.47
1.09
2.1
2.4
mg/l
10.3
11.1
0.30
27
166
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
67
1.80
1.05
1.2
2.0
—
—
—
0
0
(4306422)
16
98
1.64
1.03
1.1
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
22
2.28
1.03
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
34
2.07
1.03
2.3
3.8
u/ml
306.4
1093.4
—
7
34
(3016879) Cocaine [Presence] in Urine
24
163
1.48
1.02
6.0
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
52
405
1.30
1.01
7.0
13.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
20
131
1.54
1.00
1.5
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
35
2.01
1.00
1.7
3.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
18
115
1.58
1.00
1.2
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
33
240
1.39
0.99
1.3
1.8
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
111
945
1.20
0.99
6.1
7.3
mmol/l
103.9
104.5
0.53
111
926
(3035320) C reactive protein [Mass/volume] in Body fluid
9
49
1.84
0.98
1.9
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
44
337
1.32
0.97
1.0
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
233
1.39
0.96
2.8
2.9
u/ml
0.4
0.4
0.26
16
126
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
31
0.00
0.96
0.0
1.3
—
12.7
—
0
21
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
22
317
0.69
0.96
1.6
1.7
mg/l
2.2
5.3
0.91
17
220
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
65
526
1.25
0.95
2.0
1.9
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
51
1.77
0.94
1.3
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
117
1.55
0.94
1.3
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
16
101
1.59
0.94
1.0
1.1
%
118.3
116.1
0.10
16
90
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
34
252
1.36
0.93
2.1
1.8
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
12
70
1.72
0.93
1.1
1.8
—
—
—
0
0
(3012544) pH of Venous blood
84
702
1.22
0.92
3.2
3.9
—
7.4
—
0
5
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
78
1.68
0.92
1.1
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
28
2.15
0.91
1.0
15.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
16
102
1.58
0.91
1.0
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
25
177
1.42
0.89
1.2
3.6
umol/l
25.1
36.4
4.15
20
147
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
56
1.79
0.88
1.1
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
220
2001
1.13
0.85
1.7
1.6
mmol/l
1.5
1.4
0.89
194
1663
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
96
1.57
0.84
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
66
795
0.82
0.84
1.4
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
27
197
1.38
0.83
2.1
1.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
8
46
1.75
0.82
1.1
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
40
509
0.78
0.82
1.4
1.5
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
6
32
1.88
0.82
7.3
3.3
mu/l
40.7
30.4
—
6
32
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
155
1.43
0.81
1.5
1.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
8
47
1.71
0.80
1.5
1.8
—
43.0
—
0
6
(3027945) Reticulocytes/100 erythrocytes in Blood
86
732
1.19
0.80
1.7
2.5
%
1.8
1.8
0.00
77
649
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
169
1517
1.14
0.80
1.6
1.6
pmol/l
425.3
33386381.9
1.70
152
1267
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
6
33
1.82
0.79
1.0
1.1
u/l
4.5
8.1
—
6
27
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
48
1.67
0.79
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
43
340
1.28
0.78
3.9
3.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
74
1.63
0.78
1.1
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
27
0.00
0.77
0.0
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
99
1.52
0.76
1.3
1.2
u/ml
2.0
4.5
—
6
45
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
167
1.39
0.74
1.3
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
19
133
1.44
0.74
7.4
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
21
150
1.41
0.74
4.0
3.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
193
1.36
0.74
1.4
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
92
1.53
0.72
1.1
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
34
265
1.29
0.71
1.3
1.9
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
26
1.93
0.70
1.6
2.9
—
—
—
0
0
(3017704) Immunofixation for Urine
7
41
1.71
0.70
1.3
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
93
1.51
0.69
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
253
2347
1.11
0.69
4.0
4.0
%
22.6
22.1
0.19
109
1136
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
49
401
1.23
0.69
2.0
3.5
pmol/l
4.4
4.5
0.28
39
364
(3000492) Spirometry study
79
678
1.18
0.69
1.4
1.4
—
—
—
0
0
(4094501)
28
213
1.32
0.69
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
41
329
1.26
0.69
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
61
1.65
0.68
1.3
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
5
27
1.86
0.68
1.0
1.2
—
40.5
—
0
8
(3027923) C peptide [Moles/volume] in Serum or Plasma
7
42
1.67
0.68
1.6
1.2
nmol/l
0.8
1.3
—
7
33
(46235355) HIV 1 and 2 tests - Meaningful Use set
110
972
1.15
0.67
1.7
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
65
550
1.20
0.67
1.9
2.7
e9/l
65.1
70.2
0.65
48
415
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
28
1.79
0.66
2.2
2.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
62
1.62
0.65
1.9
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
95
1.48
0.64
1.1
1.7
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
5
29
1.73
0.64
1.2
1.0
—
0.2
—
0
6
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
112
1.44
0.63
1.1
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
63
1.59
0.62
1.4
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
14
96
1.47
0.61
1.1
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
30
1.67
0.61
3.8
10.7
—
68.4
—
0
16
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
30
1.67
0.61
1.6
2.2
umol/l
43.0
50.4
—
5
22
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
0
20
0.00
0.60
0.0
1.2
—
24.9
—
0
13
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
87
763
1.15
0.60
1.6
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
52
1.54
0.59
1.0
1.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
74
642
1.17
0.59
2.2
2.4
ug/l
6.6
8.1
0.28
66
568
(3037121) Protein [Mass/volume] in Urine
31
246
1.27
0.59
4.1
3.7
g/l
0.1
0.3
2.78
12
108
(4268621)
10
64
1.57
0.58
1.9
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
175
1.32
0.58
1.1
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
23
175
1.32
0.58
2.8
2.2
g/l
0.0
0.0
0.00
23
159
(3007566) Smooth muscle Ab [Titer] in Serum
23
175
1.32
0.58
1.1
1.2
—
75.8
—
0
12
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
23
0.00
0.58
0.0
1.1
—
318.0
—
0
15
(3048929) Epstein Barr virus Ab [Presence] in Serum
24
184
1.31
0.58
1.3
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
45
374
1.21
0.57
2.8
3.5
mmol/l
25.4
25.0
0.27
45
363
(3019225) pH of Specimen
76
664
1.16
0.56
3.3
4.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
73
1.51
0.56
2.2
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
248
1.26
0.56
2.0
2.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
184
1700
1.10
0.56
3.1
2.8
ug/l
0.6
0.8
1.56
115
1074
(40768793) Breast Pathology biopsy report
13
183
0.71
0.55
1.3
1.4
—
—
—
0
0
(44790049)
13
90
1.45
0.55
1.5
1.5
—
—
—
0
0
(44806118)
13
90
1.45
0.55
1.5
1.5
—
—
—
0
0
(44790048)
13
90
1.45
0.55
1.5
1.5
—
—
—
0
0
(44790047)
13
90
1.45
0.55
1.5
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
104
932
1.13
0.54
1.9
1.7
%
1.5
1.5
0.02
92
818
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
23
178
1.30
0.53
1.8
2.0
iu/l
1.9
4.5
—
8
69
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
31
250
1.25
0.53
1.5
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
312
2959
1.08
0.53
2.2
2.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
63
1.43
0.52
1.1
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
97
0.62
0.52
2.8
2.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
83
1.45
0.52
1.6
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
109
1.38
0.51
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
46
1.53
0.48
1.1
1.3
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
54
467
1.17
0.47
2.5
3.4
g/l
129.7
129.7
0.00
54
458
(40760888) Immunoglobulin light chains.free panel - Serum
19
146
1.31
0.47
2.4
4.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
48
1.46
0.47
1.1
1.9
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
23
182
1.27
0.46
1.1
1.2
—
1088.6
—
0
7
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
246
1.23
0.46
2.5
2.1
g/l
4.0
3.7
0.59
24
173
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
82
0.61
0.46
1.4
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
11
77
1.43
0.45
1.1
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
48
413
1.17
0.45
1.5
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
21
166
1.27
0.43
4.8
3.4
mg/l
19.5
25.1
—
8
104
(3042111) Morphology [Interpretation] in Bone marrow Narrative
15
113
1.33
0.43
1.6
1.8
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
5.3
—
35.2
—
0
6
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.0
—
1.3
—
0
9
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
15
0.00
0.41
0.0
2.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
17
0.00
0.40
0.0
2.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
150
1.27
0.40
1.2
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
150
1.27
0.40
1.2
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
18
0.00
0.40
0.0
1.5
—
2.5
—
0
18
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
65
581
1.13
0.38
1.3
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
36
1.39
0.38
2.0
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
88
802
1.11
0.38
3.7
4.7
ug/l
65.7
26.3
0.28
69
666
(3011288) Drugs identified in Urine by Screen method
15
116
1.30
0.37
2.3
2.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
72
1.39
0.37
3.9
3.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
24
198
1.22
0.36
1.3
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
79
0.63
0.35
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
79
0.63
0.35
1.4
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
153
1.25
0.35
1.4
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
10
73
1.37
0.34
1.9
1.8
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
44
1.37
0.34
1.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
29
246
1.18
0.34
2.6
2.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
11
82
1.35
0.34
1.2
1.0
—
3.3
—
0
24
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
13
100
1.30
0.33
1.2
1.1
—
10.4
—
0
6
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
88
0.68
0.33
1.2
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
68
617
1.11
0.33
7.8
9.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
90
0.66
0.33
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
90
0.66
0.33
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
90
0.66
0.33
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
90
0.66
0.33
1.3
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
16
128
1.25
0.32
1.9
2.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
193
1.20
0.31
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
100
0.70
0.30
1.4
1.5
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
19
157
1.21
0.29
4.0
4.1
kpa
5.2
5.1
0.39
19
152
(3012501) Base excess in Blood by calculation
19
157
1.21
0.29
3.9
4.1
mmol/l
4.1
2.5
0.49
14
110
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
38
335
1.14
0.29
3.6
3.8
mmol/l
24.8
24.2
0.53
32
309
(3003694) ABO and Rh group [Type] in Blood
210
2008
1.06
0.29
1.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
176
1.20
0.29
1.3
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
105
982
1.08
0.28
1.6
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
12
94
1.28
0.28
1.8
2.4
pg
33.3
32.3
0.39
12
94
(3044927) Protein electrophoresis panel - Urine
8
63
1.27
0.27
1.0
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
33
290
1.14
0.27
1.7
2.1
ug/l
0.6
1.5
1.10
27
268
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
71
0.70
0.26
1.0
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
73
0.68
0.26
2.0
2.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
75
0.66
0.26
1.2
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
75
0.66
0.26
1.2
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
75
0.66
0.26
1.2
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
5
75
0.66
0.26
1.2
1.2
mosm/kgh2o
277.2
279.5
—
5
53
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
84
0.71
0.24
1.0
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
84
0.71
0.24
1.0
1.5
—
—
—
0
0
(4281824)
6
84
0.71
0.24
1.3
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
85
0.70
0.24
1.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
85
0.70
0.24
1.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
85
0.70
0.24
1.0
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.2
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
38
1.32
0.23
1.2
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.2
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
74
690
1.08
0.22
3.4
3.7
mmol/l
2.4
1.9
0.68
62
540
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
10
79
1.27
0.22
1.0
1.1
%
104.6
95.9
—
10
74
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
2.1
—
0
10
(3051101) Glucose [Moles/volume] in Cord blood
0
12
0.00
0.21
0.0
6.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
126
1.19
0.21
1.3
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
89
1.24
0.21
1.2
1.7
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
13
0.00
0.21
0.0
4.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
21
183
1.15
0.20
1.2
1.3
miu/ml
135.3
275.5
—
10
83
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
15
176
0.85
0.20
2.3
3.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
50
1.20
0.19
1.2
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
50
1.20
0.19
1.5
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
22
193
1.14
0.19
1.5
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
12
99
1.21
0.19
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
52
1.15
0.19
1.0
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
16
185
0.86
0.18
1.2
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
58
1.21
0.18
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
62
581
1.07
0.18
4.2
3.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
7
60
1.17
0.18
1.0
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
62
1.13
0.17
2.7
3.4
u/ml
16.0
58.4
—
7
62
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
68
0.73
0.17
2.2
2.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
236
0.89
0.17
1.6
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
69
0.72
0.17
1.0
4.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
68
1.18
0.16
1.1
1.4
g/l
1.0
1.0
—
8
68
(3027315) Oxygen [Partial pressure] in Blood
18
158
1.14
0.16
4.2
4.2
kpa
7.9
8.6
0.78
18
153
(21494890) Protein electrophoresis panel - 24 hour Urine
8
71
1.13
0.16
1.7
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
83
1.21
0.15
1.2
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
78
1.16
0.15
1.1
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
78
1.16
0.15
1.2
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
129
0.85
0.14
1.1
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
90
0.78
0.14
1.3
2.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
41
439
0.93
0.14
7.3
8.7
mmol/l
25.0
24.8
0.12
41
433
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
43
458
0.94
0.13
1.2
1.2
iu/ml
204.4
144.1
0.34
15
172
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
40
375
1.07
0.12
10.1
11.9
mmol/l
24.5
24.5
0.03
35
360
(1761482) Bacteria [#/volume] in Urine by Culture
21
192
1.10
0.11
3.1
5.0
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
22
202
1.09
0.10
1.4
1.7
mu/l
293.6
326.7
0.21
22
191
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.2
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
45
1.11
0.10
2.6
2.6
—
648.8
—
0
17
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
97
1.14
0.09
1.4
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
54
1.11
0.09
2.7
4.1
—
—
—
0
0
(3002256) Pathology report gross observation
98
953
1.03
0.08
1.3
1.3
—
—
—
0
0
(4035726)
73
706
1.04
0.08
1.4
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
61
0.82
0.08
1.8
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
256
0.94
0.08
1.7
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
72
0.83
0.07
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
80
0.87
0.07
1.1
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
85
0.82
0.07
1.0
1.5
—
—
—
0
0
(4146454)
9
85
1.06
0.07
2.8
2.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
128
1.10
0.06
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
30
285
1.05
0.06
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
131
0.91
0.05
1.3
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
39
405
0.96
0.05
1.6
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
32
307
1.04
0.05
3.2
3.8
u/ml
84.5
12656.9
0.82
25
269
(3009542) Hematocrit [Volume Fraction] of Blood
693
6950
0.99
0.04
17.6
13.9
%
40.3
40.1
0.21
504
5052
(3020961) Endomysium IgA Ab [Titer] in Serum
30
290
1.04
0.03
1.3
1.1
titre
213.0
83.9
—
5
8
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
113
1.06
0.02
1.3
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
134
1.05
0.00
1.9
1.6
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
11
108
1.02
0.00
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
11
108
1.02
0.00
1.3
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
90
896
1.00
0.00
4.4
4.3
%
31.6
32.0
0.13
66
587
(3050129) First trimester maternal screen panel - Serum or Plasma
10
103
0.97
0.00
1.2
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
155
0.97
0.00
1.2
1.6
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
77
0.91
0.00
2.1
1.3
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
9
0.00
0.00
0.0
8.2
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
21.2
—
0
6
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
72
0.97
0.00
1.3
1.2
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
8.9
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
5
0.00
0.00
0.0
1.2
—
7.6
—
0
5
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
54
0.93
0.00
1.2
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
93
0.97
0.00
1.1
1.7
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
54
0.93
0.00
1.0
1.7
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_CARTILAGE and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_CARTILAGE | 1.362 [1.0, 1.85] | 0.05 |
| Birth year | 0.98 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 796 males with M13_CARTILAGE died.
Mortality risk
Mortality risk for people of age
years, who have M13_CARTILAGE.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.249% |
| 5 | No data | 1.259% |
| 10 | No data | 3.205% |
| 15 | No data | 5.826% |
| 20 | No data | 9.971% |
Relationships between endpoints
↥Index endpoint: M13_CARTILAGE – Other articular cartilage disorders
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data